Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Mamm Genome ; 32(6): 457-465, 2021 12.
Article in English | MEDLINE | ID: mdl-34272987

ABSTRACT

The heart is one of the most common organs involved in sepsis-induced organ dysfunction and about 50% septic patients complicated with myocardial injury. So far, the molecular mechanisms underlying sepsis-induced cardiac damage remain unclear. In this study we aimed to evaluate the effect of miR-642a on sepsis-induced cardiac injury in vitro and explore the possible lncRNA-microRNA mechanism. We first downloaded GSE101639 to identify differentially expressed genes (DEGs) in sepsis. The expression of miR-642a in LPS-induced H9C2 cells was detected by qRT-PCR. MTT assay, cell migration, flow cytometry analysis, ELISA, qRT-PCR and Western blotting analysis were applied to evaluating the effect of miR-642a mimic on LPS-induced H9C2 cells. The bioinformatics analysis and the rescue experiment were devoted to the underlying mechanism. The results showed miR-642a expression was decreased in septic patients and LPS-induced H9C2 cells. Besides, MiR-642a mimic promoted cell viability and migration, inhibited cell apoptosis of LPS-induced H9C2 cells. Bioinformatics analysis showed miR-642a directly targets with 3'-UTR of ROCK1. Moreover, LUCAT1 regulated ROCK1 expression act as a competing endogenous RNA (ceRNA) for miR-642a. Our data demonstrated that lncRNA LUCAT1 could function via sponging miR-642a to regulate ROCK1 expression in LPS-induced H9C2 cells. And knockdown of lncRNA LUCAT1 could suppress LPS-induced cardiac injury in vitro.


Subject(s)
MicroRNAs , Myocytes, Cardiac , RNA, Long Noncoding , Sepsis , Apoptosis/genetics , Gene Knockdown Techniques , Humans , Lipopolysaccharides , MicroRNAs/genetics , MicroRNAs/metabolism , Myocytes, Cardiac/metabolism , Myocytes, Cardiac/pathology , RNA, Long Noncoding/genetics , RNA, Long Noncoding/metabolism , Sepsis/genetics , Sepsis/pathology , rho-Associated Kinases/metabolism , rho-Associated Kinases/pharmacology
2.
J Cell Biochem ; 120(5): 8723-8730, 2019 May.
Article in English | MEDLINE | ID: mdl-30536412

ABSTRACT

BACKGROUND: Small-cell lung cancer (SCLC) is one of the most aggressive cancers with mechanisms far from understood. OBJECTIVE: We proposed to identify valuable prognostic signature for SCLC prognosis prediction. METHODS: microRNA (miRNA) expression profiles of 42 SCLC patients were acquired from the Gene Expression Omnibus. miRNAs that significantly associated with SCLC overall survival (OS-relevant) were identified through univariate Cox regression analysis followed by random survival forest analysis for identification of more reliable miRNA signature. RESULTS: Eleven OS-relevant miRNAs were obtained, and hsa-miR-194, hsa-miR-608, and hsa-miR-9 were further refined through RFS. A formula composed of the three miRNAs' expression values weighted by their multivariate Cox regression coefficients was constructed, and based on which, SCLC patients with longer OS could be well distinguished from those with shorter OS. CONCLUSIONS: This study should provide a valuable clue for SCLC prognosis evaluation.

3.
Med Sci Monit ; 22: 5173-5180, 2016 Dec 28.
Article in English | MEDLINE | ID: mdl-28029146

ABSTRACT

BACKGROUND Sepsis can cause serious acute kidney injury in bacterium-infected patients, especially in intensive care patients. Luteolin, a bioactive flavonoid, has renal protection and anti-inflammatory effects. This study aimed to investigate the effect and underlying mechanism of luteolin in attenuating lipopolysaccharide (LPS)-induced renal injury. MATERIAL AND METHODS ICR mice were treated with LPS (25 mg/kg) with or without luteolin pre-treatment (40 mg/kg for three days). The renal function, histological changes, degree of oxidative stress, and tubular apoptosis in these mice were examined. The effects of luteolin on LPS-induced expression of renal tumor necrosis factor-α (TNF-α), NF-κB, MCP-1, ICAM-1, and cleaved caspase-3 were evaluated. RESULTS LPS resulted in rapid renal damage of mice, increased level of blood urea nitrogen (BUN), and serum creatinine (Scr), tubular necrosis, and increased oxidative stress, whereas luteolin pre-treatment could attenuate this renal damage and improve the renal functions significantly. Treatment with LPS increased TNF-α, NF-κB, IL-1ß, cleaved caspase-3, MCP-1, and ICAM-1 expression, while these disturbed expressions were reversed by luteolin pre-treatment. CONCLUSIONS These results indicate that luteolin ameliorates LPS-mediated nephrotoxicity via improving renal oxidant status, decreasing NF-κB activation and inflammatory and apoptosis factors, and then disturbing the expression of apoptosis-related proteins.


Subject(s)
Acute Kidney Injury/drug therapy , Acute Kidney Injury/prevention & control , Luteolin/therapeutic use , Protective Agents/therapeutic use , Acute Kidney Injury/blood , Acute Kidney Injury/physiopathology , Animals , Apoptosis/drug effects , Blood Urea Nitrogen , Caspase 3/metabolism , Chemokine CCL2/metabolism , DNA Fragmentation/drug effects , Disease Models, Animal , Immunohistochemistry , Intercellular Adhesion Molecule-1/metabolism , Interleukin-1beta/metabolism , Kidney/drug effects , Kidney/pathology , Kidney/physiopathology , Kidney Function Tests , Lipopolysaccharides , Luteolin/pharmacology , Male , Mice, Inbred ICR , NF-kappa B/metabolism , Oxidative Stress/drug effects , Protective Agents/pharmacology , Tumor Necrosis Factor-alpha
4.
Anticancer Drugs ; 26(6): 649-56, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25811965

ABSTRACT

Matrix metalloproteinases (MMPs) secreted by ovarian cancer play essential roles in tumor invasion and metastasis. In this study, we investigated the effect of baicalein, which is isolated from the traditional Chinese herbal medicine Scutellaria baicalensis Georgi, on human ovarian cancer cell lines by measuring MMP-2 expression, invasive potential, and the underlying molecular mechanisms. Analysis of MMP-2 was carried out by western blots and RT-PCR. The invasion ability of ovarian cancer cells was determined using a Transwell invasion assay. Nuclear factor-κB (NF-κB) and p38 MAPK activation was assessed by western blots. The results of the present study showed that baicalein reduced the expression of MMP-2 in a dose-dependent manner and the invasion of ovarian cancer cells was also significantly suppressed by baicalein. We also found that baicalein reduced the activation of NF-κB signaling molecules; in addition, the MMP-2 expression and invasion ability of ovarian cancer cells were abolished with the treatment of the NF-κB inhibitor, pyrrolidine dithiocarbamate. However, the addition of p38 MAPK inhibitor SB203580 significantly reduced the activation of NF-κB; meanwhile, baicalein was shown to exert an inhibitory effect on p38 activation. Furthermore, the MMP-2 expression and invasion ability of ovarian cancer cells were significantly inhibited by SB203580. In conclusion, baicalein inhibits the MMP-2 expression and invasion ability of ovarian cancer cells, possibly by the p38 MAPK-dependent NF-κB signaling pathway; these findings may provide insights into the potential of using baicalein as a therapeutic strategy against ovarian cancer.


Subject(s)
Antineoplastic Agents/pharmacology , Flavanones/pharmacology , Matrix Metalloproteinase 2/metabolism , NF-kappa B/metabolism , Ovarian Neoplasms/metabolism , p38 Mitogen-Activated Protein Kinases/metabolism , Cell Line, Tumor/drug effects , Cell Movement/drug effects , Cell Survival/drug effects , Female , Humans , Neoplasm Invasiveness , Ovarian Neoplasms/pathology , Signal Transduction
SELECTION OF CITATIONS
SEARCH DETAIL
...